Bio-link Australia Pty. Ltd.

Bio-Link co-Executive Director, Christopher Boyer, presents at BioMelbourne Network’s Biotech Development Lab 2018

BioMelbourne Network held a symposium in August to explore how drug development, and the biotech and pharma sectors more broadly, are changing in the 21st century. Christopher Boyer spoke about commercial strategy approaches in his presentation entitled “De-risking preclinical assets with early human insights; recent advances in human tissue and disease models.” View the slides here.